Incyte CorporationSEC Filings
|
|
All SEC filings by Incyte Corporation (INCY) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Jul 28, 2026 | |
| ARS | Annual report to shareholders | Apr 28, 2026 | ||
| 10-Q | Quarterly report | View Diff | Apr 28, 2026 | |
| 10-K | Annual report | View Diff | Feb 10, 2026 | |
| 10-Q | Quarterly report | View Diff | Oct 28, 2025 | |
| 10-Q | Quarterly report | View Diff | Jul 29, 2025 | |
| ARS | Annual report to shareholders | Apr 29, 2025 | ||
| 10-Q | Quarterly report | View Diff | Apr 29, 2025 | |
| 10-K | Annual report | View Diff | Feb 10, 2025 | |
| 10-Q | Quarterly report | View Diff | Oct 29, 2024 |
Events
| 8-K | Current report | Aug 31, 2026 | ||
| 8-K | Incyte Reports Second Quarter 2026 Financial Results and Provides Business Updates | Jul 28, 2026 | ||
| 8-K | Incyte Completes Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding Its Hematology Portfolio | Jul 6, 2026 | ||
| 8-K | Current report | Jun 22, 2026 | ||
| 8-K | Current report | Jun 9, 2026 | ||
| 8-K | Current report | Jun 8, 2026 | ||
| 8-K | Incyte Reports First Quarter 2026 Financial Results and Provides Business Updates | Apr 28, 2026 | ||
| 8-K | Departure of Directors or Certain Officers | Mar 30, 2026 | ||
| 8-K | Incyte Announces Executive Leadership Appointments | Mar 26, 2026 | ||
| 8-K | Other Events | Mar 6, 2026 |
Registrations and Prospectuses
| S-8 | Registration of securities for employees | Jul 2, 2025 | ||
| S-8 | Registration of securities for employees | Jun 18, 2025 | ||
| S-8 | Registration of securities for employees | Jun 18, 2025 | ||
| S-3ASR | Automatic shelf registration | Feb 10, 2025 | ||
| SC TO-I/A | Issuer tender offer statement | Jun 13, 2024 | ||
| SC TO-I/A | Issuer tender offer statement | Jun 11, 2024 | ||
| SC TO-I/A | Issuer tender offer statement | Jun 4, 2024 | ||
| SC TO-I/A | Issuer tender offer statement | May 15, 2024 | ||
| SC TO-I | Issuer tender offer statement | May 13, 2024 | ||
| SC TO-C | Information about tender offer | May 13, 2024 |
Proxies
| DEFA14A | Additional proxy soliciting materials | May 27, 2026 | ||
| DEFA14A | Additional proxy soliciting materials | Apr 28, 2026 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 28, 2026 | |
| DEFA14A | Additional proxy soliciting materials | Apr 29, 2025 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 29, 2025 | |
| DEFA14A | Additional proxy soliciting materials | May 30, 2024 | ||
| DEFA14A | Additional proxy soliciting materials | Apr 29, 2024 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 29, 2024 | |
| DEFA14A | Additional proxy soliciting materials | Jun 7, 2023 | ||
| DEFA14A | Additional proxy soliciting materials | Apr 28, 2023 |
Other
| UPLOAD | Letter from SEC | Apr 13, 2020 | ||
| CORRESP | Correspondence with SEC | Apr 7, 2020 | ||
| UPLOAD | Letter from SEC | Mar 25, 2020 | ||
| SEC STAFF | SEC staff action: Order | Feb 27, 2020 | ||
| SEC STAFF | SEC staff action: Order | Feb 6, 2020 | ||
| CT ORDER | Confidential treatment order | Nov 7, 2019 | ||
| CT ORDER | Confidential treatment order | Nov 7, 2019 | ||
| CT ORDER | Confidential treatment order | Nov 7, 2019 | ||
| CT ORDER | Confidential treatment order | Nov 7, 2019 | ||
| CT ORDER | Confidential treatment order | Nov 7, 2019 |
Ownership
| 4 | Basi Ramitpal K | Aug 27, 2026 | ||
| 4 | Cagnoni Pablo J | Aug 20, 2026 | ||
| 144 | Notice of proposed sale of securities | Aug 19, 2026 | ||
| 4 | Cagnoni Pablo J | Aug 14, 2026 | ||
| 144 | Notice of proposed sale of securities | Aug 12, 2026 | ||
| 4 | Cagnoni Pablo J | Aug 7, 2026 | ||
| 4 | Mayes Patrick A | Aug 7, 2026 | ||
| 144 | Notice of proposed sale of securities | Aug 5, 2026 | ||
| 144 | Notice of proposed sale of securities | Aug 5, 2026 | ||
| 4 | Cagnoni Pablo J | Aug 4, 2026 |